Business Economy


Yamaha celebrates 10 yrs operations in Chennai facility

Chennai, June 4 (UNI) India Yamaha Motor (IYM) Pvt. Ltd. on Wedensday commemorated a significant milestone in its manufacturing journey with the completion of 10 years of operations
at its Chennai factory.
Reinforcing its role as a critical production base for both domestic and global markets, the company also celebrated the roll-out of its 5 millionth two-wheeler from this state-of-the-art facility—an Aerox 155 Version S that marked the milestone.
Over the past decade, the Chennai plant has become a cornerstone of Yamaha’s global operations to serve both Indian customers and export markets. It currently manufactures Yamaha’s hybrid scooter range including the RayZR 125 Fi and Fascino 125 Fi, along with the performance-oriented Aerox 155 Version S.
From an export standpoint, the facility also produces the FZ series, the Saluto range, and the Alpha scooter—reinforcing the factory’s role in delivering Yamaha's trusted quality to diverse global markets.
More than 30% of the factory’s total output is exported, reflecting its manufacturing strength and global relevance, according to a company statement.
Speaking on the occasion, Mr. Itaru Otani, Chairman, Yamaha Motor India Group of Companies,
said “The Chennai factory holds strategic importance in Yamaha’s global manufacturing network. It exemplifies our unwavering focus on people, processes, and products—driven by skilled employees, synchronized operations, and a strong commitment to global quality standards.
As one of Yamaha’s most modern manufacturing facilities worldwide, it has supported India’s mobility aspirations while reinforcing its role as a trusted exporter to global markets.
As we celebrate the roll-out of the 5 millionth two-wheeler, I extend my deepest appreciation to our dedicated employees, vendor partners and passionate customers who have made this journey possible.
"We will continue to progress, and Chennai factory will keep playing a major role in addressing the evolving customer demands in Indian and overseas markets”, he said.
Spread across 177 acres, the Chennai factory operates with a unique integrated model—109 acres dedicated to IYM and 68 acres to co-located vendor partners—enabling seamless synchronization under a unified ‘One Factory’ concept. This approach has enhanced manufacturing efficiency, speed, and supply chain integration, making the facility one of Yamaha’s most advanced in the world.
Over the last decade, the Chennai manufacturing facility has been consistently upgraded to support Yamaha's evolving premium product strategy—producing high value-added motorcycles and scooters with small to midrange engine displacements.
With India’s stringent emission regulations, Yamaha Motor Company Ltd. identified an opportunity to position this plant as a global export hub, delivering products that meet the highest standards of performance and compliance.
Today, the factory supports Yamaha’s portfolio across segments—ranging from premium models for Indian customers to those tailored for markets in Europe, Latin America, ASEAN, and beyond.
With its focus on quality, digital systems, and sustainable technologies, the facility is well-prepared for the future of smart and eco-friendly manufacturing.
UNI GV1655
More News

ADVISORY : Story withdrawn

07 Jun 2025 | 10:49 PM

EDS: File nos DC 11 and 12 - Zee5 unveils new brand identity, is being withdrawn, on the request of the company. They will issue a new release later.

see more..

Atria Renewabic launches rooftop solar campaign

07 Jun 2025 | 8:25 PM

Bengaluru, June 7 (UNI) Atria Renewabic, a frontrunner in India's renewable energy sector, on Saturday launched a unique community-centric rooftop solar campaign aimed at accelerating solar adoption in Bengaluru’s residential neighbourhoods.

see more..

Lupin gets tentative approval from U S FDA for Oxcarbazepine ER Tablets

07 Jun 2025 | 8:16 PM

Hyderabad, June 7 (UNI) Global pharma major Lupin Limited (Lupin) announced on Saturday that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Oxcarbazepine Extended-Release (ER) Tablets, 150 mg, 300 mg, and 600 mg.
This product would be manufactured at Lupin’s Nagpur facility in India, the Pharma company said in
a release.

see more..

G Square Group announces mega township project in Coimbatore

07 Jun 2025 | 8:14 PM

Hyderabad, June 7 (UNI) G Square Group, a leading South Indian real estate developer, on
Saturday announced G Square Seven Hills, an expansive township project in Coimbatore.

see more..

Aditya Birla Jewellery opens its outlet in Patna

07 Jun 2025 | 7:27 PM

Patna, June 07 (UNI) Indriya, the jewellery brand from the Aditya Birla Group, has launched its second outlet in Patna, reflecting the city’s growing appreciation for craftsmanship and exquisite design.

see more..